Akero Therapeutics Cash Flow Statement 2018-2024 | AKRO

Fifteen years of historical annual cash flow statements for Akero Therapeutics (AKRO).

Annual Data | Millions of US $ except per share data

Metric Name
Net Income/Loss
Total Depreciation And Amortization - Cash Flow
Other Non-Cash Items
Total Non-Cash Items
Change In Accounts Receivable
Change In Inventories
Change In Accounts Payable
Change In Assets/Liabilities
Total Change In Assets/Liabilities
Cash Flow From Operating Activities
Net Change In Property, Plant, And Equipment
Net Change In Intangible Assets
Net Acquisitions/Divestitures
Net Change In Short-term Investments
Net Change In Long-Term Investments
Net Change In Investments - Total
Investing Activities - Other
Cash Flow From Investing Activities
Net Long-Term Debt
Net Current Debt
Debt Issuance/Retirement Net - Total
Net Common Equity Issued/Repurchased
Net Total Equity Issued/Repurchased
Total Common And Preferred Stock Dividends Paid
Financial Activities - Other
Cash Flow From Financial Activities
Net Cash Flow
Stock-Based Compensation
Common Stock Dividends Paid
202320222021202020192018
$-151.76$-112.03$-100.78$-79.21$-43.76$-81.71
$-9.08$0.24$1.11$0.10$-0.10$0
$22.14$23.74$10.26$6.22$1.77$76.03
$13.06$23.98$11.37$6.32$1.67$76.03
$0$0$0$0$0$0
$0$0$0$0$0$0
$-0.65$0.97$3.27$2.48$-0.43$1.31
$-6.97$1.91$-2.28$-1.52$-0.51$-1.06
$-6.67$-4.46$9.73$2.09$6.46$1.06
$-145.37$-92.52$-79.68$-70.80$-35.63$-4.63
$0$0$0$-0.15$0$0
$0$0$0$0$0$0
$0$0$0$0$0$-5.00
$-223.62$-63.83$42.28$-9.61$-71.51$0
$0$0$0$0$0$0
$-223.62$-63.83$42.28$-9.61$-71.51$0
$0$0$0$0$0$0
$-223.62$-63.83$42.28$-9.76$-71.51$-5.00
$15.00$10.00$0$0$0$0
$0$0$0$0$0$0
$15.00$10.00$0$0$0$0
$339$246$1.12$203$95.99$0.01
$339$246$1.12$203$95.99$85.51
$0$0$0$0$0$0
$-0.78$-0.86$-0.52$0.05$0$-0.50
$353$256$0.60$203$95.99$85.01
$-15.67$99.29$-36.80$123$-11.15$75.38
$21.50$23.24$10.05$6.02$1.77$0.12
$0$0$0$0$0$0